Stay updated on Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the site's version history.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.2 is now displayed and the previous government funding lapse notice (v3.4.1) has been removed.SummaryDifference0.4%

- Check78 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status; updated to Revision: v3.4.1 (removing Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedAdded a Show glossary UI option and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and the Revision: v3.4.0 note; these are minor textual and interface changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.